These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3100425)

  • 1. [Imipenem resistance in Pseudomonas aeruginosa].
    Bauernfeind A; Hörl G
    Immun Infekt; 1986 Nov; 14(6):221-4. PubMed ID: 3100425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
    Lerner SA; Quinn JP
    Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characterization of imipenem resistance in Pseudomonas aeruginosa: decreased phenotypic expression of outer membrane proteins D1 and D2].
    Cullmann W; Büscher KH; Opferkuch W
    Immun Infekt; 1986 Nov; 14(6):227-9. PubMed ID: 3100427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics.
    Philippon A
    Chemioterapia; 1985 Dec; 4(6):424-8. PubMed ID: 3938346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of resistance in imipenem therapy in Pseudomonas aeruginosa].
    Krech T; Naumann P
    Immun Infekt; 1986 Nov; 14(6):224-6. PubMed ID: 3100426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selection of resistant variants by broad spectrum beta-lactam antibiotics: to what extent is there cross resistance between imipenem and other beta-lactam antibiotics?].
    Kahan F; Kropp H
    Immun Infekt; 1986 Nov; 14(6):232-5. PubMed ID: 3100429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. En bloc transduction of imipenem resistance with other resistance determinants from a clinical strain of Pseudomonas aeruginosa.
    Babálová M; Blahová J; Hupková-Lesická M; Krcméry V; Schäfer V
    J Chemother; 1996 Feb; 8(1):43-6. PubMed ID: 8835107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
    Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O
    Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipenem antagonism of the in vitro activity of piperacillin against Pseudomonas aeruginosa.
    Bertram MA; Young LS
    Antimicrob Agents Chemother; 1984 Aug; 26(2):272-4. PubMed ID: 6435517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species].
    Schröter G; Schrettenbrunner A; Strenzel I
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosa.
    Tausk F; Evans ME; Patterson LS; Federspiel CF; Stratton CW
    Antimicrob Agents Chemother; 1985 Jul; 28(1):41-5. PubMed ID: 3929679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bi-modal transfer of antibiotic resistance by conjugation and transduction from an imipenem-resistant strain of Pseudomonas aeruginosa.
    Babálová M; Blahová J; Lesická-Hupková M; Králiková K; Krcméry V; Schaefer V
    Zentralbl Bakteriol; 1995 Nov; 283(1):61-8. PubMed ID: 9810646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to imipenem in Pseudomonas aeruginosa.
    King A; Shannon K; Phillips I
    J Antimicrob Chemother; 1995 Dec; 36(6):1037-41. PubMed ID: 8821603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa.
    Lister PD; Wolter DJ
    Clin Infect Dis; 2005 Feb; 40 Suppl 2():S105-14. PubMed ID: 15712098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of emergence of Pseudomonas aeruginosa resistance to beta-lactam antibiotics in intensive care units.
    Georges B; Conil JM; Dubouix A; Archambaud M; Bonnet E; Saivin S; Lauwers-Cancès V; Cristini C; Cougot P; Decun JF; Mathe O; Chabanon G; Marty N; Seguin T; Houin G
    Crit Care Med; 2006 Jun; 34(6):1636-41. PubMed ID: 16557152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of in vitro selected resistance of Pseudomonas aeruginosa to cefoperazone, ceftazidime, azthreonam and imipenem.
    Van der Auwera P; Husson M; Bulliard G
    Drugs Exp Clin Res; 1986; 12(11):871-83. PubMed ID: 3102194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program.
    Turner PJ
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):341-4. PubMed ID: 17049798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pseudomonas aeruginosa: bactericidal activity on various beta-lactam resistance phenotypes of 8 antibiotics and 7 combinations].
    Dubrous P; Cavallo JD; Hernandez E; Nordmann P; Fabre R
    Pathol Biol (Paris); 1997 May; 45(5):433-7. PubMed ID: 9296099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity of imipenem: the first thienamycin antibiotic.
    Kropp H; Gerckens L; Sundelof JG; Kahan FM
    Rev Infect Dis; 1985; 7 Suppl 3():S389-410. PubMed ID: 3931196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics.
    Martino P; Venditti M; Valente B; Brandimarte C; Serra P
    Drugs Exp Clin Res; 1985; 11(4):247-51. PubMed ID: 3939121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.